-
1
-
-
0025336568
-
Breakthrough pain: Definition, prevalence and characteristics
-
Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273-281.
-
(1990)
Pain
, vol.41
, pp. 273-281
-
-
Portenoy, R.K.1
Hagen, N.A.2
-
2
-
-
33846982239
-
Weighing in on the off-label use of Actiq for noncancer-related pain: A recipe for success or a recipe for disaster?
-
Passik SD, Kirsh KL. Weighing in on the off-label use of Actiq for noncancer-related pain: a recipe for success or a recipe for disaster? Pain Med 2007; 8: 130-133.
-
(2007)
Pain Med
, vol.8
, pp. 130-133
-
-
Passik, S.D.1
Kirsh, K.L.2
-
3
-
-
39649107318
-
Is actiq use in noncancer-related pain really 'a recipe for success'?
-
O'Connor AB. Is actiq use in noncancer-related pain really 'a recipe for success'? Pain Med 2008; 9: 258-260.
-
(2008)
Pain Med
, vol.9
, pp. 258-260
-
-
O'Connor, A.B.1
-
4
-
-
43549093045
-
Not so fast: The reformulation of fentanyl and breakthrough chronic non-cancer pain
-
Markman JD. Not so fast: the reformulation of fentanyl and breakthrough chronic non-cancer pain. Pain 2008; 136: 227-229.
-
(2008)
Pain
, vol.136
, pp. 227-229
-
-
Markman, J.D.1
-
5
-
-
49649099082
-
Efficacy of opioids for chronic pain: A review of the evidence
-
Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008; 24: 469-478.
-
(2008)
Clin J Pain
, vol.24
, pp. 469-478
-
-
Ballantyne, J.C.1
Shin, N.S.2
-
6
-
-
34547606540
-
Opioid misuse in oncology pain patients
-
Ballantyne JC. Opioid misuse in oncology pain patients. Curt Pain Headache Rep 2007; 11:276-282.
-
(2007)
Curt Pain Headache Rep
, vol.11
, pp. 276-282
-
-
Ballantyne, J.C.1
-
7
-
-
34248578775
-
Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics
-
Bennett DS, Simon S, Brennan M, Shoemaker SA. Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics. J Opioid Manag 2007; 3: 101-106.
-
(2007)
J Opioid Manag
, vol.3
, pp. 101-106
-
-
Bennett, D.S.1
Simon, S.2
Brennan, M.3
Shoemaker, S.A.4
-
8
-
-
0036468726
-
Episodic (breakthrough) pain: Consensus conference of an expert working group of the European Association for Palliative Care
-
Mercadante S, Radbruch L, Caraceni A et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 2002; 94: 832-839.
-
(2002)
Cancer
, vol.94
, pp. 832-839
-
-
Mercadante, S.1
Radbruch, L.2
Caraceni, A.3
-
9
-
-
33746559173
-
Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain
-
Portenoy RK, Bennett DS, Rauck R et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain 2006; 7: 583-591.
-
(2006)
J Pain
, vol.7
, pp. 583-591
-
-
Portenoy, R.K.1
Bennett, D.S.2
Rauck, R.3
-
10
-
-
33947279540
-
Breakthrough pain in opioid-treated patients with neuropathic pain
-
Simon S, Bennett DS, Rauck R, Taylor D, Shoemaker S. Breakthrough pain in opioid-treated patients with neuropathic pain. J Opioid Manag 2006; 2: 347-352.
-
(2006)
J Opioid Manag
, vol.2
, pp. 347-352
-
-
Simon, S.1
Bennett, D.S.2
Rauck, R.3
Taylor, D.4
Shoemaker, S.5
-
11
-
-
33846692601
-
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: A randomized, placebo-controlled study
-
Portenoy RK, Messina J, Xie F, Peppin J. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study. Curt Med Res Opin 2007; 23:223-233.
-
(2007)
Curt Med Res Opin
, vol.23
, pp. 223-233
-
-
Portenoy, R.K.1
Messina, J.2
Xie, F.3
Peppin, J.4
-
12
-
-
34347328100
-
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: A multicenter, randomized, double-blind, placebo-controlled study
-
Simpson DM, Messina J, Xie F, Hale M. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2007; 29: 588-601.
-
(2007)
Clin Ther
, vol.29
, pp. 588-601
-
-
Simpson, D.M.1
Messina, J.2
Xie, F.3
Hale, M.4
-
13
-
-
33947356595
-
Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ)
-
Taylor DR, Webster LR, Chun SY et al. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ). Pain Med 2007; 8: 281-288.
-
(2007)
Pain Med
, vol.8
, pp. 281-288
-
-
Taylor, D.R.1
Webster, L.R.2
Chun, S.Y.3
-
14
-
-
29244473555
-
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
-
Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81: 103-107.
-
(2006)
Drug Alcohol Depend
, vol.81
, pp. 103-107
-
-
Compton, W.M.1
Volkow, N.D.2
-
15
-
-
34248569302
-
Opioid dependence and addiction during opioid treatment of chronic pain
-
Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235-255.
-
(2007)
Pain
, vol.129
, pp. 235-255
-
-
Ballantyne, J.C.1
LaForge, K.S.2
-
16
-
-
0026410297
-
Pharmacokinetic considerations in abuse liability evaluation
-
Farre M, Caml J. Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 1991; 86: 1601-1606.
-
(1991)
Br J Addict
, vol.86
, pp. 1601-1606
-
-
Farre, M.1
Caml, J.2
-
18
-
-
0035500599
-
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males
-
Roset PN, Farre M, de la Torre R et al. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend 2001; 64: 285-298.
-
(2001)
Drug Alcohol Depend
, vol.64
, pp. 285-298
-
-
Roset, P.N.1
Farre, M.2
De La Torre, R.3
-
19
-
-
22444449424
-
Evidence of addiction by anesthesiologists as documented by hair analysis
-
Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005; 153: 81-84.
-
(2005)
Forensic Sci Int
, vol.153
, pp. 81-84
-
-
Kintz, P.1
Villain, M.2
Dumestre, V.3
Cirimele, V.4
-
20
-
-
77949355307
-
-
Risk Evaluation and Mitigation Strategies (REMS) and Opioid Analgesics Webinar. (last accessed 16/02/2010)
-
Risk Evaluation and Mitigation Strategies (REMS) and Opioid Analgesics Webinar. www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucml63655.htm (last accessed 16/02/2010)
-
-
-
-
21
-
-
33846423929
-
Opioid prescriptions soar: Increase in legitimate use as well as abuse
-
Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007; 297: 249-251.
-
(2007)
JAMA
, vol.297
, pp. 249-251
-
-
Kuehn, B.M.1
-
22
-
-
77949422143
-
U.S. opioid risk management initiatives
-
Ballantyne JC. U.S. Opioid risk management initiatives. Pain: Clinical Updates 2009; 17: 1-5.
-
(2009)
Pain: Clinical Updates
, vol.17
, pp. 1-5
-
-
Ballantyne, J.C.1
-
23
-
-
67650449895
-
Drug companies and doctors: A story of corruption
-
(last accessed 09/02/2010)
-
Angell M. Drug companies and doctors: a story of corruption. The New York Review of Books 2009; 56. www.nybooks.com/articles/22237 (last accessed 09/02/2010)
-
(2009)
The New York Review of Books
, vol.56
-
-
Angell, M.1
|